Elisa Gallerani
- Oncology top 10%
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 4
-
- Cancer Genomics and Diagnostics 6
- Reproductive Medicine top 10%
-
- Lung Cancer Treatments and Mutations 5
- Advanced Breast Cancer Therapies 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Cristiana SessaLuca GianniDagmar HessLucia ViganòSilvia MarsoniAlberta LocatelliUlrike Gnad-VogtGianluca Del Conte
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Journal of Clinical Oncology (15 papers)Clinical Cancer Research (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- SwitzerlandItalyUnited Kingdom
In The Last Decade
Elisa Gallerani
41 papers receiving 758 citations
Peers
Comparison fields: 5 of 77
- Oncology 427
- Immunology 149
- Cancer Research 93
- Reproductive Medicine 52
- Pulmonary and Respiratory Medicine 160
Countries citing papers authored by Elisa Gallerani
This map shows the geographic impact of Elisa Gallerani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Gallerani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Gallerani more than expected).
Fields of papers citing papers by Elisa Gallerani
This network shows the impact of papers produced by Elisa Gallerani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Gallerani. The network helps show where Elisa Gallerani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisa Gallerani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 1 | |
| 4 | 2020 | 3 | |
| 5 | 2015 | 18 | |
| 6 | 2014 | 14 | |
| 7 | 2014 | 88 | |
| 8 | 2014 | 1 | |
| 9 | 2014 | 16 | |
| 10 | 2013 | 26 | |
| 11 | 2013 | 14 | |
| 12 | 2012 | 94 | |
| 13 | 2012 | 45 | |
| 14 | 2010 | 11 | |
| 15 | 2009 | 29 | |
| 16 | 2008 | 28 | |
| 17 | 2008 | 41 | |
| 18 | Cetuximab dose-escalation study in patients with metastatic colorectal cancer (MCRC) with no or slight skin reactions on cetuximab standard dose treatment (Everest): Preliminary PK and efficacy data of a randomized study | 2006 | 7 |
| 19 | 2006 | 10 | |
| 20 | 2001 | 17 |
About Elisa Gallerani
Elisa Gallerani is a scholar working on Oncology, Cancer Research and Hepatology, having authored 42 papers that have together received 773 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (7 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer therapeutics and mechanisms (4 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (427 citations), Immunology (149 citations) and Cancer Research (93 citations). Elisa Gallerani has collaborated with scholars based in Switzerland, Italy and United Kingdom. Frequent co-authors include Cristiana Sessa, Luca Gianni, Dagmar Hess, Lucia Viganò, Silvia Marsoni, Alberta Locatelli, Ulrike Gnad-Vogt, Gianluca Del Conte, Filippo de Braud and Guido Biasco. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.